1. Home
  2. ALVO
Logo Alvotech

ALVO

Alvotech

as 05-24-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Founded: 2013 Country:
Iceland
Iceland
Employees: N/A City: N/A
Market Cap: 3.8B IPO Year: N/A
Target Price: $16.00 AVG Volume (30 days): 226.0K
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.08 EPS Growth: N/A
52 Week Low/High: $6.70 - $18.00 Next Earning Date: 05-21-2024
Revenue: $114,393,000 Revenue Growth: 14.27%
Revenue Growth (this year): 247.98% Revenue Growth (next year): 90.36%

ALVO Daily Stock ML Predictions

Share on Social Networks: